Protara Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Highlights Progress in Clinical Pipeline BVN Q4 2025 Earnings Strong EPS Surprise Driven by Operational Gains PRK Q1 2026 Earnings EPS Falls Short of Estimates Shares Edge Higher Landstar System LSTR Q1 2026 Earnings EPS Beats Estimates Modestly Stock Edges Higher CTAS Q1 2026 Earnings EPS Misses Estimates Stock Sees Modest Gain NAT Q4 2025 Earnings Significant EPS Miss Sends Stock Lower